The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGF<i>β</i> Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A

<div>Expression of 14 mRNA in the HaCaT culture treated with LPS+adalimumab (RTqPCR results) presented as fold change in expression when compared to a control culture.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGF<i>β</i> Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A 

Figure 2 | The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGFβ Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A 